GGrantIndex
← Leaderboards

Guido Erwin Michael Eibl

University Of California Los Angeles

$7,914,971
Attributed
$8,383,687
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,247,856 · 12

By mechanism

P01$16,875,527 · 8
R01$2,569,888 · 2
UH2$404,972 · 1
R21$397,469 · 1

Top collaborators

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasm Of Pancreas

Research focus

Malignant Neoplasm Of PancreasTumorAnimal ModelDietPancreatic AdenocarcinomaObesityPancreasMalignant NeoplasmsDesignProgramsGrowthCancer PreventionMouse ModelPancreatic Intraepithelial NeoplasiaResearch PersonnelFatty Acid Glycerol EstersPreventChemopreventionBiologicalGeneticInflammatoryAnimalsDietary ComponentCell Culture Techniques

Grant awards (43)

Impact of dietary lipids on pancreas cancer initiation and progression$147,263
UH2 · FY2025 · CA
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma$1,088,453
P01 · FY2024 · CA · contact PI
Core 1: Animal and Cell Model Core$280,106
P01 · FY2024 · CA · contact PI
Impact of dietary lipids on pancreas cancer initiation and progression$257,709
UH2 · FY2024 · CA
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer$231,494
P01 · FY2024 · CA · contact PI
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma$1,122,823
P01 · FY2023 · CA · contact PI
Core 1: Animal and Cell Model Core$285,729
P01 · FY2023 · CA · contact PI
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer$238,094
P01 · FY2023 · CA · contact PI
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression$178,679
R21 · FY2023 · CA
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma$1,122,822
P01 · FY2022 · CA · contact PI
Core 1: Animal and Cell Model Core$286,979
P01 · FY2022 · CA · contact PI
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer$238,368
P01 · FY2022 · CA · contact PI
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression$218,790
R21 · FY2022 · CA
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma$1,145,739
P01 · FY2021 · CA · contact PI
Core 1: Animal and Cell Model Core$291,562
P01 · FY2021 · CA · contact PI
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer$242,952
P01 · FY2021 · CA · contact PI
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma$1,159,739
P01 · FY2020 · CA · contact PI
Core 1: Animal and Cell Model Core$294,995
P01 · FY2020 · CA · contact PI
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer$245,813
P01 · FY2020 · CA · contact PI
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma$1,304,539
P01 · FY2016 · CA · contact PI
Animal Core$278,984
P01 · FY2016 · CA · contact PI
Inflammatory processes In diet-Induced pancreatic cancer promotion$220,594
P01 · FY2016 · CA · contact PI
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma$1,221,579
P01 · FY2015 · CA · contact PI
Animal Core$262,379
P01 · FY2015 · CA · contact PI
Inflammatory processes In diet-Induced pancreatic cancer promotion$205,008
P01 · FY2015 · CA · contact PI
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma$1,237,917
P01 · FY2014 · CA · contact PI
Animal Core$265,748
P01 · FY2014 · CA · contact PI
Inflammatory processes In diet-Induced pancreatic cancer promotion$206,488
P01 · FY2014 · CA · contact PI
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma$1,207,024
P01 · FY2013 · CA · contact PI
Animal Core$258,336
P01 · FY2013 · CA · contact PI
Inflammatory processes In diet-Induced pancreatic cancer promotion$200,797
P01 · FY2013 · CA · contact PI
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma$1,253,534
P01 · FY2012 · CA · contact PI
Animal Core$270,056
P01 · FY2012 · CA · contact PI
Inflammatory processes In diet-Induced pancreatic cancer promotion$206,876
P01 · FY2012 · CA · contact PI
The role of n-3 polyunsaturated fatty acids in pancreatic cancer$283,822
R01 · FY2011 · CA · contact PI
The role of n-3 polyunsaturated fatty acids in pancreatic cancer$292,600
R01 · FY2010 · CA · contact PI
The role of n-3 polyunsaturated fatty acids in pancreatic cancer$292,600
R01 · FY2009 · CA · contact PI
The role of n-3 polyunsaturated fatty acids in pancreatic cancer$292,600
R01 · FY2008 · CA · contact PI
The role of n-3 polyunsaturated fatty acids in pancreatic cancer$292,600
R01 · FY2007 · CA · contact PI
The Role of COX-2 and PPAR-Gamma in Pancreatic Cancer$270,281
R01 · FY2007 · CA · contact PI
The Role of COX-2 and PPAR-Gamma in Pancreatic Cancer$278,354
R01 · FY2006 · CA · contact PI
The Role of COX-2 and PPAR-Gamma in Pancreatic Cancer$284,438
R01 · FY2005 · CA
The Role of COX-2 and PPAR-Gamma in Pancreatic Cancer$282,593
R01 · FY2004 · CA